The European Commission announced Wednesday it has reached a deal with a sixth pharmaceutical firm, this time BioNTech-Pfizer, to reserve a further 200 million doses
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
